Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravenous Ketorolac Administration to Attenuate Post-procedural Pain Associated With Intrauterine Device Placement: A Randomized, Double-Blind, Placebo-Controlled Trial

NCT05875571 is registered in ClinicalTrials.gov with Arkansas Children's Hospital Research Institute as lead sponsor.

NCT NCT05875571
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05875571 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravenous Ketorolac Administration to Attenuate Post-procedural Pain Associated With Intrauterine Device Placement: A Randomized, Double-Blind, Placebo-Controlled Trial
Lead sponsor
Arkansas Children's Hospital Research Institute
Phase
Phase 4
Overall status
Unknown status
Start date
February 5, 2024
Completion date
June 30, 2025
Enrollment
18 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

contraception, healthy female, iud, iud insertion complication